Screener
Omnicell OMCL Connected devices, software licenses, and other — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Omnicell in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Omnicell’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000926326-26-000022
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Connected devices, software licenses, and other | $149,227 | $138,620 | $297,889 | $258,697 |
| Consumables | 25,835 | 24,552 | 51,973 | 49,643 |
| Technical services | 68,552 | 63,766 | 135,475 | 125,145 |
| SaaS and Expert Services | 68,594 | 63,624 | 136,751 | 126,745 |
| Total revenues | $312,208 | $290,562 | $622,088 | $560,230 |
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Omnicell's connected devices, software licenses, and other — total revenues?
- Omnicell (OMCL) reported connected devices, software licenses, and other — total revenues of $149.23M in Q2 2026.
- How has Omnicell's connected devices, software licenses, and other — total revenues changed year-over-year?
- Omnicell's connected devices, software licenses, and other — total revenues increased by 7.7% year-over-year, from $138.62M to $149.23M.
- What is the long-term trend for Omnicell's connected devices, software licenses, and other — total revenues?
- Over 4 years (2021 to 2025), Omnicell's connected devices, software licenses, and other — total revenues has grown at a -6.5% compound annual growth rate (CAGR), from $739.07M to $565.48M.
- What does connected devices, software licenses, and other — total revenues mean?
- This metric represents the total revenue generated from the sale of hardware-enabled connected devices, perpetual or term software licenses, and ancillary services within the medication management portfolio. It captures the initial capital-intensive or transactional revenue streams associated with deploying automation technology and software infrastructure in healthcare settings. Tracking this revenue helps investors assess the company's ability to secure new installations and expand its technological footprint within hospitals and pharmacies.
Ask your AI about Omnicell's connected devices, software licenses, and other — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude